Institute of Chemical Biology
The Institute of Chemical Biology (ICB), [named as Institute of Biology, Medicinal Chemistry and Biotechnology (IBMCB) until 6/5/2019] was founded in February 2012 from the merger of the Institutes of Biological Research and Biotechnology (IBRB) and Organic and Pharmaceutical Chemistry (IOPC) of the National Hellenic Research Foundation. The two components of the new Institute have a long presence in the Greek research ecosystem, successfully conducting high-level scientific research; the IBRB since 1977 in the areas of Biological Sciences and Biotechnology, and the IOPC since 1989 in the fields of Organic, Organometallic and Medicinal Chemistry.
The key objective of ICB is to capitalise on the strengths of the two pre-existing Institutes to promote research, education and innovation thus, maximizing the added value and synergies of the merger. ICB aims to develop cutting-edge research and innovation through a modern interdisciplinary approach at the interface of Chemistry and Biology, unique in Greece, to solve cutting-edge issues in the areas of health, Drug discovery and biotechnology, exploiting the unique combination of expertise and infrastructure of the new Institute.